Ledger.Open graph →
SEC Form D · Amendment · filed February 4, 2022

GLO Pharma, Inc

Offering
$23.0M
Sold
$22.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Carlsbad, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Nicole Quinn · Carlsbad, CADirectorScott Glenn · Carlsbad, CAExec · DirectorTodd Jackson · Carlsbad, CADirectorLauren Otsuki · Carlsbad, CADirectorCarol Shen · Carlsbad, CADirectorDan Dearborn · Tampa, FLExec · DirectorJeff Stinson · Little Rock, ARDirectorTyler Carrico · SAN FRANCISCO, CADirectorDerive Ventures GP I, LLC · SAN FRANCISCO, CADirectorMichael Scott · SAN FRANCISCO, CADirectorJacob B. Jones · Raleigh, NCDirectorGordon V. Tucker · Raleigh, NCDirectorJeffrey G. Brock · Raleigh, NCDirectorNicolas T. Giauque · San Francisco, CADirectorSteve Howard · Singapore, U0Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗